Literature DB >> 23555386

Compression sclerotherapy for primary valvular insufficiency -from liquid to foam-.

Takashi Yamaki1.   

Abstract

The history of sclerotherapy of varicose veins of lower extremities dates back to 1840's. The use of stronger sclerosants thereafter led to serious complications, and the use of sclerotherapy decreased for varicose veins. However, sclerotherapy again became popular after introduction of safer sclerosant and compression sclerotherapy. After introduction of sclerosing foam in mid 1990's, many phlebologists are now in favor of the use of sclerosing foam instead of the use of sclerosing liquid. However, few studies have focused on the efficacy of sclerosing foam compared with that of sclerosing liquid in sclerotherapy of venous insufficiency. In Europe, the 1(st) and 2(nd) European Consensus Meetings on Foam Sclerotherapy (ECMFS) were already taken place in Germany. In this review, we discuss the efficacy of sclerosant foam in comparison with liquid form. Furthermore, solved and unsolved questions on safety aspect of foam sclerotherapy are also discussed.

Entities:  

Keywords:  superficial venous insufficiency; ultrasound-guided foam sclerotherapy; varicose veins

Year:  2010        PMID: 23555386      PMCID: PMC3595807          DOI: 10.3400/avd.AVDrev09037

Source DB:  PubMed          Journal:  Ann Vasc Dis        ISSN: 1881-641X


  26 in total

1.  Guidelines for sclerotherapy of varicose veins (ICD 10: I83.0, I83.1, I83.2, and I83.9).

Authors:  E Rabe; F Pannier-Fischer; H Gerlach; F X Breu; S Guggenbichler; M Zabel
Journal:  Dermatol Surg       Date:  2004-05       Impact factor: 3.398

2.  Microvascular embolization following polidocanol microfoam sclerosant administration.

Authors:  David M Eckmann; Shunji Kobayashi; Min Li
Journal:  Dermatol Surg       Date:  2005-06       Impact factor: 3.398

Review 3.  Foam and liquid sclerotherapy for varicose veins.

Authors:  Philip Coleridge Smith
Journal:  Phlebology       Date:  2009       Impact factor: 1.740

4.  [Newer aspects in the technique of treating varicosities].

Authors:  K SIGG
Journal:  Ther Umsch       Date:  1949-12

5.  Assessment of techniques to reduce sclerosant foam migration during ultrasound-guided sclerotherapy of the great saphenous vein.

Authors:  Douglas Hill; Rhonda Hamilton; Tak Fung
Journal:  J Vasc Surg       Date:  2008-08-09       Impact factor: 4.268

6.  Multiple small-dose injections can reduce the passage of sclerosant foam into deep veins during foam sclerotherapy for varicose veins.

Authors:  T Yamaki; M Nozaki; H Sakurai; M Takeuchi; K Soejima; T Kono
Journal:  Eur J Vasc Endovasc Surg       Date:  2008-10-14       Impact factor: 7.069

7.  Evaluation of the efficacy of polidocanol in the form of foam compared with liquid form in sclerotherapy of the greater saphenous vein: initial results.

Authors:  Claudine Hamel-Desnos; Philippe Desnos; Jan-Christoph Wollmann; Pierre Ouvry; Serge Mako; François-Andre Allaert
Journal:  Dermatol Surg       Date:  2003-12       Impact factor: 3.398

8.  Comparative study of duplex-guided foam sclerotherapy and duplex-guided liquid sclerotherapy for the treatment of superficial venous insufficiency.

Authors:  Takashi Yamaki; Motohiro Nozaki; Susumu Iwasaka
Journal:  Dermatol Surg       Date:  2004-05       Impact factor: 3.398

9.  Correction of lower extremity deep venous incompetence by ablation of superficial venous reflux.

Authors:  C M Sales; M L Bilof; K A Petrillo; N L Luka
Journal:  Ann Vasc Surg       Date:  1996-03       Impact factor: 1.466

10.  Femoral venous reflux abolished by greater saphenous vein stripping.

Authors:  J C Walsh; J J Bergan; S Beeman; T P Comer
Journal:  Ann Vasc Surg       Date:  1994-11       Impact factor: 1.466

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.